Aortic Valve (TAVR/TAVI)Wednesday, May 27, 2026
Jefferies Financial Group Inc. Cuts Stake in Edwards Lifesciences Corporation $EW - MarketBeat
1 min read·By E. Nolan Beckett, MD·Source: MarketBeat
From The Valve Wire
The TAVR-explant problem is now a number we can quote at heart team meetings. [NOTABLE] A narrative review of four studies and 35,677 patients pegs operative mortality of redo SAVR after TAVR at 12-17% versus 1.1-9% after prior SAVR , with propensity-matched odds ratios as high as 12.5 and observed-to-expected ratios exceeding 1.0 even in low-risk patients.
TAVR-SAVR volume is growing at up to 144.6% annually and may eclipse SAVR-SAVR by 2029.
Editor’s take pending for this article; this is the section commentary excerpt.
Source Abstract
Jefferies Financial Group Inc. Cuts Stake in Edwards Lifesciences Corporation $EW MarketBeat
Read the Original
Full article at MarketBeat
Open at MarketBeat →The Valve Wire summarizes; we link out to primary sources for verification.
More in Aortic Valve (TAVR/TAVI)
- Aortic Valve (TAVR/TAVI)· Giornale italiano di cardiologia (2006)[Ventricular tachycardia and left bundle branch block after transcatheter aortic valve implantation: is the valve guilty forever or not?].
- Aortic Valve (TAVR/TAVI)· American heart journal plus : cardiology research and practiceClinical outcomes following transcatheter aortic valve replacement in patients with concordant versus discordant aortic stenosis.
- Aortic Valve (TAVR/TAVI)· CureusAssociation of Comorbidity Burden With In-Hospital Mortality in Transcatheter Aortic Valve Replacement Patients With Coexisting Malignancy in the United States: A Retrospective Cohort Study.
Elsewhere in Today’s Issue
- Mitral Valve (Repair & Replacement)· Cardiovascular intervention and therapeuticsUse of TriClip steerable guide catheter for MitraClip: from bench to case.
- Mitral Valve (Repair & Replacement)· JACC. Cardiovascular interventionsPercutaneous Annuloplasty Followed by TEER for Tricuspid Regurgitation: A Multicenter Experience.
- Mitral Valve (Repair & Replacement)· JACC. Cardiovascular interventionsImpact of Coronary Artery Disease and Revascularization on Outcomes After Transcatheter Tricuspid Edge-to-Edge Repair.